Prostaglandin endoperoxide synthase: structure and catalysis - PubMed (original) (raw)

Review

Prostaglandin endoperoxide synthase: structure and catalysis

W L Smith et al. Biochim Biophys Acta. 1991.

No abstract available

PubMed Disclaimer

Similar articles

• Prostaglandin endoperoxide synthase contains an EGF-like domain.
  Toh H. Toh H. FEBS Lett. 1989 Dec 4;258(2):317-9. doi: 10.1016/0014-5793(89)81683-7. FEBS Lett. 1989. PMID: 2513231
• Independent prostanoid biosynthetic systems associated with prostaglandin endoperoxide synthases-1 and -2.
  Smith WL, DeWitt DL, Arakawa T, Spencer AG, Thuresson ED, Song I. Smith WL, et al. Thromb Haemost. 1997 Jul;78(1):627-30. Thromb Haemost. 1997. PMID: 9198228 Review. No abstract available.
• The aspirin and heme binding sites of PGG/H synthase.
  Smith WL, DeWitt DL, Shimokawa T. Smith WL, et al. Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:77-80. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1825591 No abstract available.
• Molecular basis for the inhibition of prostanoid biosynthesis by nonsteroidal anti-inflammatory agents.
  Smith WL, DeWitt DL, Shimokawa T, Kraemer SA, Meade EA. Smith WL, et al. Stroke. 1990 Dec;21(12 Suppl):IV24-8. Stroke. 1990. PMID: 2175460
• Structure-function relationships in sheep, mouse, and human prostaglandin endoperoxide G/H synthases.
  Smith WL, DeWitt DL, Kraemer SA, Andrews MJ, Hla T, Maciag T, Shimokawa T. Smith WL, et al. Adv Prostaglandin Thromboxane Leukot Res. 1990;20:14-21. Adv Prostaglandin Thromboxane Leukot Res. 1990. PMID: 2144687 Review.

Cited by

• Physical evidence for substrate binding in preventing cyclooxygenase inactivation under nitrative stress.
  Deeb RS, Cheung C, Nuriel T, Lamon BD, Upmacis RK, Gross SS, Hajjar DP. Deeb RS, et al. J Am Chem Soc. 2010 Mar 24;132(11):3914-22. doi: 10.1021/ja910578y. J Am Chem Soc. 2010. PMID: 20196542 Free PMC article.
• Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia.
  del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. del Zoppo G, et al. Brain Pathol. 2000 Jan;10(1):95-112. doi: 10.1111/j.1750-3639.2000.tb00247.x. Brain Pathol. 2000. PMID: 10668900 Free PMC article. Review.
• Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
  Gao S, Tian B, Han J, Zhang J, Shi Y, Lv Q, Li K. Gao S, et al. Int J Nanomedicine. 2019 Aug 2;14:6135-6150. doi: 10.2147/IJN.S205295. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31447556 Free PMC article.
• Cyclooxygenase products and atherosclerosis.
  Linton MF, Fazio S. Linton MF, et al. Drug Discov Today Ther Strateg. 2008;5(1):25-36. doi: 10.1016/j.ddstr.2008.05.006. Drug Discov Today Ther Strateg. 2008. PMID: 19343100 Free PMC article. No abstract available.
• Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation.
  Calzada C, Vericel E, Lagarde M. Calzada C, et al. Biochem J. 1997 Jul 15;325 ( Pt 2)(Pt 2):495-500. doi: 10.1042/bj3250495. Biochem J. 1997. PMID: 9230133 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database